← Leaderboards
Donald J. Krogstad
Tulane University Of Louisiana
$3,813,373
Attributed
$3,813,373
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2005–16$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$13,182,094 · 7
FDA$1,198,838 · 1
By mechanism
U19$12,671,501 · 2
R01$1,198,838 · 1
R21$371,605 · 1
M01$138,988 · 4
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- John C. C. Beier$7,134,563
- Ellie Osir$1,059,609
- Charles Mbogo$1,059,609
- John I Githure$1,059,609
- Sarah Kay Volkman$1,812,850
Others in their field
Top investigators on “Malaria”
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$82,291,297
- Stephen Lev Hoffman · Sanaria, Inc.$79,440,588
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$61,561,099
Research focus
MalariaHuman SubjectInternationalSiteBaseChildEpidemiologyResearch PersonnelSuccessAfrica South Of The Sahara5 Year OldPublic Health Medicine (Field)Population BasedFailure (Biologic Function)EnsureTransmission ProcessDrug ResistancePlasmodium FalciparumFundingFunding AgencyFoundationsGuidelinesHealth EconomicsAuthority
Grant awards (25)
Population-based Approach to Malaria Research and Control$1,689,381
U19 · FY2016 · AI · contact PI
Administrative Core$361,426
U19 · FY2016 · AI · contact PI
Population-based Approach to Malaria Research and Control$1,559,554
U19 · FY2015 · AI · contact PI
Phase 2 Studies of AQ-13, an Investigative Antimalarial$399,999
R01 · FY2015 · FD · contact PI
Administrative Core$257,335
U19 · FY2015 · AI · contact PI
Population-based Approach to Malaria Research and Control$1,456,892
U19 · FY2014 · AI · contact PI
Administrative Core$330,429
U19 · FY2014 · AI · contact PI
Phase 2 Studies of AQ-13, an Investigative Antimalarial$199,999
R01 · FY2014 · FD · contact PI
Population-based Approach to Malaria Research and Control$1,489,336
U19 · FY2013 · AI · contact PI
Administrative Core$259,468
U19 · FY2013 · AI · contact PI
Population-based Approach to Malaria Research and Control$1,509,165
U19 · FY2012 · AI · contact PI
Administrative Core$361,743
U19 · FY2012 · AI · contact PI
Phase 2 Studies of AQ-13, an Investigative Antimalarial$200,000
R01 · FY2012 · FD · contact PI
Population-based Approach to Malaria Research and Control$1,459,130
U19 · FY2011 · AI · contact PI
Administrative Core$304,523
U19 · FY2011 · AI · contact PI
Population-based Approach to Malaria Research and Control$1,404,101
U19 · FY2010 · AI · contact PI
Administrative Core$229,018
U19 · FY2010 · AI · contact PI
Phase 2 Studies of AQ-13, an Investigative Antimalarial$398,840
R01 · FY2009 · FD · contact PI
Informed Consent in Illiterate Subjects$164,318
R21 · FY2009 · AI · contact PI
Informed Consent in Illiterate Subjects$207,287
R21 · FY2008 · AI · contact PI
PHASE I AND II STUDIES OF INVESTIGATIONAL AMINOQUINOLINES$83,346
M01 · FY2006 · RR · contact PI
PHASE I AND II STUDIES OF INVESTIGATIONAL AMINOQUINOLINES$21,003
M01 · FY2005 · RR
Phase I and II Studies of Investigational Aminoquinolines$34,639
M01 · FY2004 · RR
PHASE I/II STUDIES OF INVESTIGATIONAL AMINOQUINOLINES$0
M01 · FY2001 · RR
PHASE I/II STUDIES OF INVESTIGATIONAL AMINOQUINOLINES$0
M01 · FY2000 · RR